Soteri Skin develops non-steroidal, over-the-counter topical treatments for eczema relief. Their products utilize proprietary pH science to correct and stabilize skin pH, aiming for long-term symptom management. The company offers specialized creams for active flares, long-term maintenance, and infant skin care.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Eczema sufferers often struggle with recurring symptoms due to an imbalance in the skin's natural pH, leading to irritation, itching, and inflammation. Existing topical treatments may provide temporary relief but fail to address the underlying cause of the pH imbalance, resulting in continued discomfort and reliance on steroids.
Solution
Soteri Skin offers a clinically tested topical skincare treatment that provides long-term relief from eczema by restoring the skin's acid mantle and maintaining an optimal pH balance for 12 hours. Formulated with the patented pH/LOCK™ complex, the products alleviate eczema symptoms and address the root cause of the condition. The treatment strengthens the skin barrier, soothes irritation, and reduces the need for steroid-based medications.
Target Audience
The primary target audience includes individuals suffering from eczema, parents of children with eczema, and those seeking long-term relief from eczema symptoms without the use of steroids.
Features
- Patented pH/LOCK™ complex to restore and maintain optimal skin pH levels
- Clinically tested formulas with dermatologist approval
- Steroid-free, fragrance-free, sulphate-free, and alcohol-free
- Products available for face, body, and scalp eczema
- Gentle formulations suitable for babies and sensitive skin
- Visible symptom relief within 4-6 weeks, as demonstrated in clinical trials
- Addresses the root cause of eczema by restoring the skin's acid mantle